Header Logo

Connection

Karl Simin to Mice, Transgenic

This is a "connection" page, showing publications Karl Simin has written about Mice, Transgenic.
Connection Strength

0.161
  1. Johnson JP, Kumar P, Koulnis M, Patel M, Simin K. Crucial and novel cancer drivers in a mouse model of triple-negative breast cancer. Cancer Genomics Proteomics. 2014 May-Jun; 11(3):115-26.
    View in: PubMed
    Score: 0.089
  2. Simin K, Hill R, Song Y, Zhang Q, Bash R, Cardiff RD, Yin C, Xiao A, McCarthy K, van Dyke T. Deciphering cancer complexities in genetically engineered mice. Cold Spring Harb Symp Quant Biol. 2005; 70:283-90.
    View in: PubMed
    Score: 0.046
  3. Goel HL, Pursell B, Chang C, Shaw LM, Mao J, Simin K, Kumar P, Vander Kooi CW, Shultz LD, Greiner DL, Norum JH, Toftgard R, Kuperwasser C, Mercurio AM. GLI1 regulates a novel neuropilin-2/a6?1 integrin based autocrine pathway that contributes to breast cancer initiation. EMBO Mol Med. 2013 Apr; 5(4):488-508.
    View in: PubMed
    Score: 0.020
  4. Jones JM, Elder JT, Simin K, Keller SA, Meisler MH. Insertional mutation of the hairless locus on mouse chromosome 14. Mamm Genome. 1993 Nov; 4(11):639-43.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.